Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study

Late testing and antiretroviral therapy (ART) prevailed among people living with HIV (PLHIV) and impacted the benefit of immediate ART. This study aimed to identify the benefit of the test-and-immediate-treat policy in China, the effect of immediate ART, and the influence of late testing and ART on...

Full description

Bibliographic Details
Main Authors: Qiaosen Chen, Jun Liu, Xiaobing Fu, Fang Yang, Qicai Liu, Junbin Li, Zhimin Tan, Jing Li, Kaihao Lin, Yao Yan, Yi Yang, Yan Li, Hongbo Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.851117/full
_version_ 1817976960199950336
author Qiaosen Chen
Jun Liu
Xiaobing Fu
Fang Yang
Qicai Liu
Junbin Li
Zhimin Tan
Jing Li
Kaihao Lin
Yao Yan
Yi Yang
Yan Li
Hongbo Jiang
author_facet Qiaosen Chen
Jun Liu
Xiaobing Fu
Fang Yang
Qicai Liu
Junbin Li
Zhimin Tan
Jing Li
Kaihao Lin
Yao Yan
Yi Yang
Yan Li
Hongbo Jiang
author_sort Qiaosen Chen
collection DOAJ
description Late testing and antiretroviral therapy (ART) prevailed among people living with HIV (PLHIV) and impacted the benefit of immediate ART. This study aimed to identify the benefit of the test-and-immediate-treat policy in China, the effect of immediate ART, and the influence of late testing and ART on the whole PLHIV in Guangdong Province, China. We designed two tendency analyses in aggregative form and two cohorts (surveillance and ART cohort) in individuals' perspectives based on the HIV/AIDS Comprehensive Response Information Management System. Two interrupted time series models were conducted for tendency analysis from 2009 to 2018 to explore the all-cause and short-term mortality decrease after the test-and-immediate-treat policy. A time-dependent Cox model was performed for the surveillance cohort from 1992 to 2018 and a joint model was utilized for the ART cohort to identify the effect of immediate ART and the influence of late testing and ART on death. The tendency analysis included 324,914 and 68,679 person-year for all-cause/short-term mortality. A total of 49,289 and 26,287 PLHIV were recruited in the surveillance and ART cohort with 5,557 and 459 deaths, respectively. The short-term mortality dropped from 4.69 cases/100 person-year in January 2009 to 0.35 cases/100 person-year in December 2018 (standardized rate). The all-cause mortality saw a decreasing trend from 1.46 cases/100 person-year in January 2009 to 0.14 cases/100 person-year in December 2018 (standardized rate). The tendency analysis showed a significant short-term mortality slope decrease after the test-and-immediate-treat policy (P = 0.024). From the surveillance cohort, late testing, in general, was a risk factor for all-cause mortality [hazard ratio (HR) = 1.330, 95% CI, 1.250, 1.416]. ART cohort showed higher hazards of all-cause mortality among PLHIV with no late testing, but late ART (HR = 1.690, 95% CI, 1.166, 2.451) and both the late testing and late ART (HR = 1.335, 95% CI, 1.042, 1.710). Immediate ART might decrease the hazard of all-cause death though it is insignificant (HR = 0.923, 95% CI: 0.755, 1.129) in the ART cohort. The test-and-immediate-test policy brought benefit to PLHIV. We should enlarge HIV testing using comprehensive approaches to decrease late testing and ART and increase the benefit of immediate ART.
first_indexed 2024-04-13T22:09:54Z
format Article
id doaj.art-4bc8092efd8642fb832953314a48683a
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-13T22:09:54Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-4bc8092efd8642fb832953314a48683a2022-12-22T02:27:46ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-07-011010.3389/fpubh.2022.851117851117Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort StudyQiaosen Chen0Jun Liu1Xiaobing Fu2Fang Yang3Qicai Liu4Junbin Li5Zhimin Tan6Jing Li7Kaihao Lin8Yao Yan9Yi Yang10Yan Li11Hongbo Jiang12Department of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of HIV/AIDS Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, ChinaDepartment of HIV/AIDS Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, ChinaDepartment of HIV/AIDS Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, ChinaGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, ChinaGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaDepartment of HIV/AIDS Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, ChinaLate testing and antiretroviral therapy (ART) prevailed among people living with HIV (PLHIV) and impacted the benefit of immediate ART. This study aimed to identify the benefit of the test-and-immediate-treat policy in China, the effect of immediate ART, and the influence of late testing and ART on the whole PLHIV in Guangdong Province, China. We designed two tendency analyses in aggregative form and two cohorts (surveillance and ART cohort) in individuals' perspectives based on the HIV/AIDS Comprehensive Response Information Management System. Two interrupted time series models were conducted for tendency analysis from 2009 to 2018 to explore the all-cause and short-term mortality decrease after the test-and-immediate-treat policy. A time-dependent Cox model was performed for the surveillance cohort from 1992 to 2018 and a joint model was utilized for the ART cohort to identify the effect of immediate ART and the influence of late testing and ART on death. The tendency analysis included 324,914 and 68,679 person-year for all-cause/short-term mortality. A total of 49,289 and 26,287 PLHIV were recruited in the surveillance and ART cohort with 5,557 and 459 deaths, respectively. The short-term mortality dropped from 4.69 cases/100 person-year in January 2009 to 0.35 cases/100 person-year in December 2018 (standardized rate). The all-cause mortality saw a decreasing trend from 1.46 cases/100 person-year in January 2009 to 0.14 cases/100 person-year in December 2018 (standardized rate). The tendency analysis showed a significant short-term mortality slope decrease after the test-and-immediate-treat policy (P = 0.024). From the surveillance cohort, late testing, in general, was a risk factor for all-cause mortality [hazard ratio (HR) = 1.330, 95% CI, 1.250, 1.416]. ART cohort showed higher hazards of all-cause mortality among PLHIV with no late testing, but late ART (HR = 1.690, 95% CI, 1.166, 2.451) and both the late testing and late ART (HR = 1.335, 95% CI, 1.042, 1.710). Immediate ART might decrease the hazard of all-cause death though it is insignificant (HR = 0.923, 95% CI: 0.755, 1.129) in the ART cohort. The test-and-immediate-test policy brought benefit to PLHIV. We should enlarge HIV testing using comprehensive approaches to decrease late testing and ART and increase the benefit of immediate ART.https://www.frontiersin.org/articles/10.3389/fpubh.2022.851117/fullpeople living with HIVlate testinglate antiretroviral treatmenttreat-allmortalitytrend
spellingShingle Qiaosen Chen
Jun Liu
Xiaobing Fu
Fang Yang
Qicai Liu
Junbin Li
Zhimin Tan
Jing Li
Kaihao Lin
Yao Yan
Yi Yang
Yan Li
Hongbo Jiang
Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study
Frontiers in Public Health
people living with HIV
late testing
late antiretroviral treatment
treat-all
mortality
trend
title Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study
title_full Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study
title_fullStr Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study
title_full_unstemmed Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study
title_short Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992–2018: A Cohort Study
title_sort effect of late testing and antiretroviral treatment on mortality among people living with hiv in the era of treat all in guangdong province china 1992 2018 a cohort study
topic people living with HIV
late testing
late antiretroviral treatment
treat-all
mortality
trend
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.851117/full
work_keys_str_mv AT qiaosenchen effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT junliu effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT xiaobingfu effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT fangyang effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT qicailiu effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT junbinli effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT zhimintan effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT jingli effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT kaihaolin effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT yaoyan effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT yiyang effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT yanli effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy
AT hongbojiang effectoflatetestingandantiretroviraltreatmentonmortalityamongpeoplelivingwithhivintheeraoftreatallinguangdongprovincechina19922018acohortstudy